Nearly 90percent of Yunnan Companys first half profit is the lead of non-ferrous metal plates revenue

category:Finance
 Nearly 90percent of Yunnan Companys first half profit is the lead of non-ferrous metal plates revenue


Non-ferrous Metal Matrix: Leading Revenue

Yunnan Province is located in the southwest mountainous area with abundant resources and geographical advantages. The reserves of non-ferrous metals are relatively large. The reserves of 61 minerals rank the top 10 in the country. Among them, 25 mineral resources such as lead, zinc, tin, phosphorus, copper and silver rank the top three in the country respectively. The non-ferrous metals field has always been the advantage of Yunnan plate.

In terms of performance, in the first half of 2019, seven listed companies in Yunnan non-ferrous metal sector achieved a total revenue of 79.922 billion yuan and net returns of 1.803 billion yuan. On the whole, except Chihong Zinc and Germanium (600497.SH) showed a slight decline, the revenue and net profits of the other six companies showed different degrees of growth. Trends.

It is worth mentioning that Chihong Zinc and Germanium won the first position of profitability of non-ferrous metal plate with net profit of 697 million yuan. Yunnan Copper Industry (000878.SZ) occupied the first place of metal plate revenue with 25654 million yuan, while Yunnan Germanium Industry (002428.SZ) was the only company in the plate that reported a loss in half a year. The momentum should not be underestimated, the recent surge is fierce.

Chemical Matrix: Demonstrating Strength

In the first half of this year, Yuntianhua (600096.SH), the leader of the chemical industry in Yunnan Province, succeeded in winning the first prize in the revenue of Listed Companies in Yunnan Province with a revenue of 28.402 billion yuan, an increase of 22.6% over the same period of last year, and realized a net return of 127 million yuan to mother, an increase of 91.98% over the same period of last year. At the same time, Chuan Jinnuo (300505.SZ) performed well in the first half of the year, realizing 522 million yuan in revenue, an increase of 24.59% over the same period of last year; realizing 354.06 million yuan in net returns of returned mothers, an increase of 30.70% over the same period of last year; the production and sales volume of major products increased greatly, and sales revenue increased by 24.59% over the same period of last year, which made Chuan Jinnuo achieve a net profit increase.

As for the reasons why the chemical industry has shown good performance this year, the analysts of Guojin Securities believe that under the pressure of structural reform on the supply side and environmental protection renovation, some small and medium-sized enterprises have been shut down and turned over one after another because they are unable to pay huge environmental protection costs, and the low-end production capacity has been withdrawn and concentrated on leading listed companies. Catalyzed the brilliant performance of the chemical industry plate.

In addition to the traditional chemical industry, Enjie (002812.SZ), which produces high-end lithium battery diaphragms, also has a bright performance in its semi-annual report. In the first half of this year, the company realized a revenue of 1.378 billion yuan, an increase of 41.44% over the previous year; realized a net return of 389 million yuan, an increase of 140.98% over the previous year; and its net revenue reached a record high in the same period. Become one of the best growing companies in listed Yunnan enterprises.

In addition, Yunnan Nengtie (002053.SZ) achieved a net profit of 210 million yuan, an increase of 37.98% over the same period last year, relying on its new wind power production capacity; Yunnan Coal Energy (60079.2 billion SH) achieved net profit of 102 million yuan for the first time in the first half of 2019.

Pharmaceutical Matrix: Significant Achievements

Among the 36 listed companies in Yunnan, pharmaceutical companies account for nearly 20% of the total, including Kunyao Group (600422. SH), Watson Biology (300142. SZ), Dali Pharmaceutical Industry (603963. SH), Longjin Pharmaceutical Industry (002750. SZ) and Yunnan Baiyao (000538. SZ), which focus on the research and development of pharmaceutical products.uff08 002727.SZ) takes pharmaceutical chain retail as its core business.

It is noteworthy that all pharmaceutical enterprises in Yunnan Plate made profits in the first half of the year. For this reason, the reporter of Securities Daily combed the profit and R&D expenses of all pharmaceutical enterprises in Yunnan Plate in the first half of the year.

In the first half of the year, the pharmaceutical sector in Yunnan Province realized revenue of 23.505 billion yuan, an increase of 8.98% over the same period of last year; net profit of 2.917 billion yuan, an increase of 11% over the same period of last year; according to further statistical data of the Journal of Securities, among the six listed companies mentioned above, from January to June 2019, there were four companies with total R&D investment of more than 10 million yuan, of which four were listed companies. Watson Biology, Yunnan Baiyao, Kunyu Pharmaceutical Group and Longjin Pharmaceutical Co., Ltd. had a total R&D of 205 million yuan during the reporting period.

Particular attention should be paid to the remarkable achievements in R&D and innovation of the biomedical sector in the first half of 2019. The 13-valent pneumococcal polysaccharide conjugate vaccine developed by Watson Biology is expected to be marketed within this year, becoming the second and first approved 13-valent pneumococcal conjugate vaccine in the world and in China. Tongshu capsule, a product of Yunnan Baiyao, has been approved by FDA to carry out phase II clinical research, and has become the first national medicine approved by FDA to enter clinical research. Kunyao Groups new natural drug class 1 for ischemic stroke and long-acting hypoglycemic drug Supalu peptide injection, inactivated human vaccine rotavirus vaccine of Institute of Medical Biology and Watson tetravalent influenza virus pyrolysis vaccine were approved by the National Drug Clinic.

Other Matrix: Each has its own strengths

From the securities business sector, the only two securities firms in Yunnan Province achieved a total revenue of 1.824 billion yuan in the first half of the year and a total net return of 650 million yuan. Among them, newly-promoted member Hongta Securities (60123.660 billion SH) contributed 753 million yuan in revenue, an increase of 79.4% compared with the previous year, and contributed 292 million yuan in net profit, a substantial increase of 25.192 billion yuan compared with the previous year. After Hongta Securities was officially listed in July this year, the Pacific Ocean (601099. SH), originally a single shot in Yunnan Plate, is no longer lonely, and the future of Yunnan securities business may usher in a new situation.

In the public utilities sector, Huaneng Hydropower (60002.5 billion SH) has realized revenue of 105.89 billion yuan and net profit of 2.816 billion yuan in the first half of the year, an increase of 22.477 billion yuan over the same period of last year, following Yunnan Baiyao with a total stock of 18 billion shares and a market value of 81.9 billion yuan (as of September 9, 2019). Money-making ability. Wenshan Electric Power (600995.SH) is as stable as Mount Taishan, although the growth rate in the first half of the year is small, but it is increasing steadily every year.

In recent years, the domestic tourism industry has developed rapidly. In Yunnan Province, which is famous for its tourism industry, there are only two listed tourism companies - Yunnan Tourism (002059.SZ) and Lijiang Tourism (002033.SZ). The tourism resources in Yunnan Province are still scattered and not centralized. Most of them are managed by small and medium-sized enterprises. In the first half of 2019, the two companies realized a total revenue of 1.311 billion yuan and a net return of 133 million yuan to their mothers. Their revenue and net return to their mothers declined year on year.

In addition to the above plate, Yunnan plate has added three new members this year: Huazhi Liquor Company (300755. SZ), Zhenan Science and Technology (300767. SZ) and Hongta Securities (601236. SH), which all performed well in the first half of the performance report. Among them, Huazhi Wine Companys net profit in the first half of the year was 201 million yuan, an increase of 45.40% over the previous year.

Overall, the overall performance of Yunnan plate in the first half of this year is good, medicine, non-ferrous metals, chemical industry is still the main theme; securities dealers, tourism, hydropower, especially Huaneng hydropower, once joined the Yunnan plate, it will become an absolute elder brother, Hongta Securities will become the leader of Yunnan securities dealers; and some enterprises because The industry characteristics can not reflect the real strength, such as Nantian Information, Yunnan Chengdu Investment, Yunnan Ge industry. Perhaps it will be more clear when the annual report is published.